Henry Shelford, CEO and Co-Founder of ADHD UK, was quoted in the article and provided background information.
New research has found that adults with ADHD in the UK may have significantly reduced life expectancy, with men living on average 4½ to 9 years less and women 6½ to 11 years less than those without the condition. Experts say this reflects long-standing gaps in diagnosis, treatment and ongoing care. The study also highlights that fewer than one in nine adults with ADHD receive a diagnosis, and many wait years for NHS assessment and support.
Henry Shelford, CEO and co-founder of ADHD UK, said the findings should serve as an “urgent call to action” for both the NHS and the government, emphasising that lives are being “devastated” by a lack of services and lengthy waiting times, which he personally experienced with a three-year wait for care.
You can read the full article here: https://www.independent.co.uk/news/health/adhd-diagnosis-treatment-nhs-death-b2684979.html
